ÇELİK, İ. Et Al. 2022. Synthesis, molecular docking, in silico ADME, and EGFR kinase inhibitor activity studies of some new benzimidazole derivatives bearing thiosemicarbazide, triazole, and thiadiazole. Journal of Heterocyclic Chemistry , vol.59, no.2 , 371-387.

ÇELİK, İ., Ayhan-Kılcıgil, G., Karayel, A., GÜVEN, B., & Onay-Besikci, A., (2022). Synthesis, molecular docking, in silico ADME, and EGFR kinase inhibitor activity studies of some new benzimidazole derivatives bearing thiosemicarbazide, triazole, and thiadiazole. Journal of Heterocyclic Chemistry , vol.59, no.2, 371-387.

ÇELİK, İSMAİL Et Al. "Synthesis, molecular docking, in silico ADME, and EGFR kinase inhibitor activity studies of some new benzimidazole derivatives bearing thiosemicarbazide, triazole, and thiadiazole," Journal of Heterocyclic Chemistry , vol.59, no.2, 371-387, 2022

ÇELİK, İSMAİL Et Al. "Synthesis, molecular docking, in silico ADME, and EGFR kinase inhibitor activity studies of some new benzimidazole derivatives bearing thiosemicarbazide, triazole, and thiadiazole." Journal of Heterocyclic Chemistry , vol.59, no.2, pp.371-387, 2022

ÇELİK, İ. Et Al. (2022) . "Synthesis, molecular docking, in silico ADME, and EGFR kinase inhibitor activity studies of some new benzimidazole derivatives bearing thiosemicarbazide, triazole, and thiadiazole." Journal of Heterocyclic Chemistry , vol.59, no.2, pp.371-387.

@article{article, author={İSMAİL ÇELİK Et Al. }, title={Synthesis, molecular docking, in silico ADME, and EGFR kinase inhibitor activity studies of some new benzimidazole derivatives bearing thiosemicarbazide, triazole, and thiadiazole}, journal={Journal of Heterocyclic Chemistry}, year=2022, pages={371-387} }